Faron Pharmaceuticals Ltd on Monday said results from a probe of a cancer drug were promising.
Faron shares were up 10% at 364.00 pence each in London on Monday around midday.
The Turku,.
Faron Pharmaceuticals Ltd on Tuesday said its interim loss widened on higher costs but saw shares soar after it gained a US Food & Drug Administration orphan drug designation for Bexmarilimab..
Faron Pharmaceuticals Ltd on Wednesday said data from its phase 1 BEXMAB study has shown positive data.
The Finland-based clinical-stage biopharmaceutical company said three of five patients in the.
Faron Pharmaceuticals Ltd on Monday said further data from its Phase I/II MATINS study of bexmarilimab has indicated the efficacy and safety of the immunotherapy in solid tumours.
The Turku,. | April 24, 2023
Faron Pharmaceuticals Ltd on Wednesday said it has appointed James O Brien as its new chief financial officer, effective from Monday next week, succeeding Toni Hanninen.
The Turku, Finland-based. | March 29, 2023